Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
We present a 74-year-old female patient who developed a pityriasis lichenoides chronica (PLC) during etanercept therapy. This association is not described in the literature and might be considered in the spectrum of cutaneous adverse reactions of etanercept.
Saved in:
Main Authors: | Andrés F. Echeverri (Author), Andrés Vidal (Author), Carlos A. Cañas (Author), Andrés Agualimpia (Author), Gabriel J. Tobón (Author), Fabio Bonilla-Abadía (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dupilumab for the treatment of pityriasis lichenoides chronica
by: Charissa N. Obeng-Nyarko, MS, et al.
Published: (2024) -
Dermoscopy of pityriasis lichenoides chronica in an Indian girl
by: Sidharth Sonthalia, et al.
Published: (2020) -
Localized pityriasis lichenoides chronica masquerading as lichen striatus
by: Subhra Dhar, et al.
Published: (2024) -
Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination
by: Abdullah M. Al Muqrin, MD, et al.
Published: (2022) -
Pityriasis lichenoides chronica: case reports - the role of infectious agents?
by: Anca Chiriac, et al.
Published: (2014)